Executive Salary
avg.$181,705
Johnson & Johnson
Consumer Goods Manufacturing/Drugstore, Perfumeries, Pharmacy
New Brunswick, NJ, United States
Description
Johnson & Johnson, founded in 1886, is a publicly traded healthcare company headquartered in New Brunswick, New Jersey. The company's diverse portfolio includes the development and production of pharmaceutical prescription drugs and medical device technologies. Globally, Johnson & Johnson employs approximately 138,100 people and serves both B2B and B2C markets. Its annual revenue exceeds $88.82 billion, reflecting its substantial scale in the healthcare sector. As an established leader in the industry, Johnson & Johnson operates through various subsidiaries, contributing to its broad international presence. The company is recognized for its extensive product offerings and commitment to healthcare innovation, with a significant footprint in the United States.
Experteer Insights
Experteer Briefing
Company Trajectory
Johnson & Johnson, headquartered in New Brunswick, New Jersey, United States, was established in 1886 as a manufacturer dedicated to selling ready-to-use sterile surgical dressings. Over the decades, the company evolved through strategic pivots, expanding far beyond its original product line. Johnson & Johnson’s trajectory features significant milestones such as launching subsidiaries, expanding into international markets, and developing a diversified portfolio in healthcare. The company is known for notable restructuring events and exploring new areas in pharmaceuticals and medical technology. Looking ahead, Johnson & Johnson continues to solidify its position in the global healthcare industry, focusing on innovation and product development to address emerging health concerns.
Financial Setup
Johnson & Johnson is a publicly traded company, with a global workforce exceeding 138,100 employees. Its business model has progressed from solely offering sterile dressings to developing and producing pharmaceutical prescription drugs and advanced medical device technologies. Serving both B2B and B2C customers, the company has experienced continual growth, marked by stable revenue streams and expansion through major mergers and acquisitions. This solid financial foundation underpins its ongoing investment in research, product development, and strategic market expansion.
Development & Outlook
Recent advancements at Johnson & Johnson include the introduction of pharmaceutical products targeting immune disorders, cancer, neurological, infectious, cardiovascular, and metabolic diseases, as well as a broad suite of medical devices for various medical specialties. The company holds a pivotal patent on the tuberculosis drug bedaquiline, with additional secondary patents internationally. Johnson & Johnson has demonstrated a strong commitment to public health and sustainability, notably investing over $1 billion to develop a not-for-profit COVID-19 vaccine. Social responsibility initiatives feature support for the Institute for Advanced Study and active corporate partnerships that promote diversity, equity, and inclusion. Looking forward, Johnson & Johnson remains focused on healthcare innovation, expanding its global reach, and upholding its role as a leader in responsible business practices.
Vacancies
Director, IM SCT Americas Deliver PGL
Johnson & Johnson
Titusville, NJ - USA
Key Account Territory Manager (Raleigh, NC) Johnson and Johnson MedTech, Electrophysiology
Johnson & Johnson
Raleigh, NC - USA
Staff Design Engineer, R&D
Johnson & Johnson
Cincinnati, OH - USA
R&D Primary Design Engineer
Johnson & Johnson
Cincinnati, OH - USA
Director, In Silico Discovery, CADD – San Diego, CA
Johnson & Johnson
San Diego, CA - USA